Drug intelligence / Profile preview

Healthwave-Tab

Development stage: Unknown
Lead developer: Medicox Lifescience
Modality: Small Molecules
Administration: Oral

Overview

Healthwave-Tab is a branded generic dietary supplement developed and marketed by Medicox Lifescience. Formulated as an oral tablet, it contains a combination of potent antioxidants including lutein, lycopene, and zeaxanthin. The supplement is specifically designed to support ocular health and vision clarity by protecting eye tissues from oxidative stress and filtering high-energy blue light. It is primarily indicated for adults to help safeguard against age-related eye conditions such as age-related macular degeneration (AMD) and cataracts.

Brand names: Healthwave-Tab
Other names: Healthwave

Beyond the preview

Go deeper on Healthwave-Tab.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healthwave-Tab.

Explore the full profile